ASPEN PHARMACARE HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.7 ZAR | +1.98% |
|
+1.70% | +8.46% |
| Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
| Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
Presenter SpeechKuseni Dlamini (Executives)Great honor and privilege to stand in front of you....
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows:
- pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.;
- other (28.4%): infant nutrition products and consumer products.
At the end of June 2022, the group had 16 production sites worldwide.
Sector
Pharmaceuticals
Calendar
2024-09-02
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
220.7
ZAR
Average target price
232
ZAR
Spread / Average Target
+5.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.46% | 5.22B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| -4.29% | 4.71B |
- Stock Market
- Equities
- APN Stock
- News Aspen Pharmacare Holdings Limited
- Transcript : Aspen Pharmacare Holdings Limited, 2022 Earnings Call, Sep 01, 2022
